The NYSE pre-market update on September 9, 2026, featured key developments including defense company Covenant emerging from stealth with a new factory and heavy-payload weapon system, backed by over $250 million in funding. Moonwalk Bio announced progress in RNAi treatments aimed at reducing body fat while preserving muscle, with clinical trials expected in late 2027. Additionally, Brent Crude oil prices topped $100 a barrel amid Middle East tensions, influencing market outlook ahead of upcoming inflation data. These updates provide insights into defense innovation, biotech advancements, and commodity price shifts impacting investors.
Oracle's connection to OpenAI, with about 47% of its remaining performance obligation linked to the AI firm, has shifted investor sentiment positively. Despite concerns over a $70 billion capital expenditure plan for fiscal 2027 and local resistance ...
Adobe and Oracle are set to report earnings, highlighting contrasting investment profiles. Adobe shows steady, profitable growth with a strong subscription model and solid cash flow, making it a safer choice for retirement investors despite lacking a...
Oracle's stock has fallen about 33% this year even as it booked a historic $638 billion backlog, driven by surging AI cloud infrastructure demand. The company competes with major cloud providers and has seen cloud revenue grow rapidly, but heavy capi...
Michael Burry, famed for predicting the 2008 crash, has updated his portfolio with Lululemon Athletica as his largest holding, making up about 17% of his investments. Despite this confidence, Lululemon's stock dropped 12% after disappointing quarterl...
Oracle is set to report its Q1 FY2027 earnings on September 10, with shares already up 15% due to renewed AI enthusiasm. However, the company's heavy data center commitments and a recent credit downgrade may limit upside potential. Investors are advi...
